Our findings demonstrate that these highlyselective inhibitors are nontoxic, effectively inhibit bone resorptionby human osteoclasts, block CTSK activity in cells and their nuclei,and inhibit activity in human lung cancer tissue. This evidence concerns the gene CTSK and lung carcinoma.